Moment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Buy
1,419
+27
+2% +$27.6K 0.31% 19
2026
Q1
$1.28M Buy
1,392
+23
+2% +$23.3K 0.23% 26
2025
Q4
$1.47M Buy
1,369
+4
+0.3% +$3.83K 0.3% 19
2025
Q3
$1.04M Sell
1,365
-12
-0.9% -$8.93K 0.18% 38
2025
Q2
$1.07M Hold
1,377
0.2% 35
2025
Q1
$1.14M Hold
1,377
0.23% 28
2024
Q4
$1.06M Buy
+1,377
New +$1.14M 0.2% 31

Other funds holding LLY

Moment Partners's LLY Position: Q2 2026 in Review

Moment Partners increased its Eli Lilly (LLY) stake by 1.9% in Q2 2026, buying an estimated $27.6K and bringing the position to 1,419 shares worth $1.7M. The position accounts for 0.31% of the portfolio, ranked #19.

Moment Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Moment Partners held 1,419 shares of Eli Lilly worth $1.7M as of Q2 2026.
  • Moment Partners bought 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
  • Eli Lilly made up 0.31% of Moment Partners's portfolio in Q2 2026, its #19 holding.
  • Moment Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Moment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.